David Natan - 10 Feb 2022 Form 3 Insider Report for Sunshine Biopharma, Inc (SBFM)

Role
Director
Signature
/s/ David Natan
Issuer symbol
SBFM
Transactions as of
10 Feb 2022
Net transactions value
$0
Form type
3
Filing time
18 Feb 2022, 14:25:51 UTC
Next filing
12 May 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SBFM Common Stock 0 10 Feb 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.